Skip to main content
. Author manuscript; available in PMC: 2013 Apr 17.
Published in final edited form as: J Alzheimers Dis. 2013;33(0 1):S405–S416. doi: 10.3233/JAD-2012-129026

Figure 2.

Figure 2

Progressively increasing cerebral amyloid burden disclosed by Pittsburgh Imaging Compoud B (PiB) positron emission tomohraphy with increasing APOE e4 gene dose in asymptomatic individuals age 50–69 years old, and in patients with probable Alzheimer’s disease.